Acurx Pharmaceuticals, Inc.

ACXP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-1/A Mar 29, 2024 FORM S-1/A
8-K Mar 18, 2024 FORM 8-K
S-1 Mar 18, 2024 FORM S-1
S-8 Mar 15, 2024 FORM S-8
10-K Mar 15, 2024 10-K
SC 13G/A Feb 14, 2024
4 Jan 22, 2024 OWNERSHIP DOCUMENT
4 Jan 4, 2024 OWNERSHIP DOCUMENT
4 Jan 4, 2024 OWNERSHIP DOCUMENT
8-K Nov 15, 2023 FORM 8-K
424B5 Nov 15, 2023 424B5
8-K Nov 14, 2023 FORM 8-K
10-Q Nov 13, 2023 10-Q
8-K Nov 3, 2023 FORM 8-K
8-K Oct 2, 2023 FORM 8-K
8-K Aug 14, 2023 FORM 8-K
10-Q Aug 11, 2023 10-Q
424B3 Jul 13, 2023 424B3
EFFECT Jul 10, 2023
CORRESP Jul 6, 2023
UPLOAD Jul 5, 2023
S-1 Jun 29, 2023 FORM S-1
8-K Jun 20, 2023 FORM 8-K
4 Jun 16, 2023 OWNERSHIP DOCUMENT
4 Jun 16, 2023 OWNERSHIP DOCUMENT
← Newer Page 6 of 10 · 243 filings Older →